Robust Bayesian monitoring of sequential trials
From MaRDI portal
Publication:478376
DOI10.1007/S40300-013-0008-XzbMATH Open1302.62227OpenAlexW2087327866MaRDI QIDQ478376FDOQ478376
Authors: Pierpaolo Brutti, Fulvio de Santis, Stefania Gubbiotti
Publication date: 3 December 2014
Published in: Metron (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s40300-013-0008-x
Recommendations
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical analysis (62L10)
Cites Work
- Title not available (Why is that?)
- A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
- Robust Bayesian analysis: sensitivity to the prior
- Robust Bayesian sample size determination for avoiding the range of equivalence in clinical trials
- Optimal Experimental Design for Another's Analysis
- Design of Experiment for Bioassay
- Sample Size Determination for Robust Bayesian Analysis
- Ranges of posterior measures for priors with unimodal contaminations
- Interim Analysis in Clinical Trials: The Role of the Likelihood Principle
- Robust Bayes and empirical Bayes analysis with \(\epsilon\)-contaminated priors
- Title not available (Why is that?)
- Robust Bayesian analysis in medical and epidemiological settings
Cited In (1)
This page was built for publication: Robust Bayesian monitoring of sequential trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q478376)